ATE183742T1 - 2-aminopyrazin-5-carbonsäureamid derivate, deren herstellung und deren verwendung als heilmittel - Google Patents

2-aminopyrazin-5-carbonsäureamid derivate, deren herstellung und deren verwendung als heilmittel

Info

Publication number
ATE183742T1
ATE183742T1 AT94401032T AT94401032T ATE183742T1 AT E183742 T1 ATE183742 T1 AT E183742T1 AT 94401032 T AT94401032 T AT 94401032T AT 94401032 T AT94401032 T AT 94401032T AT E183742 T1 ATE183742 T1 AT E183742T1
Authority
AT
Austria
Prior art keywords
group
hydrogen atom
aminopyrazine
remedies
production
Prior art date
Application number
AT94401032T
Other languages
English (en)
Inventor
Pascal George
Benoit Marabout
Jacques Froissant
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Application granted granted Critical
Publication of ATE183742T1 publication Critical patent/ATE183742T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D241/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT94401032T 1993-05-17 1994-05-10 2-aminopyrazin-5-carbonsäureamid derivate, deren herstellung und deren verwendung als heilmittel ATE183742T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9305930A FR2705344B1 (fr) 1993-05-17 1993-05-17 Dérivés de 2-aminopyrazine-5-carboxamide, leur préparation et leur application en thérapeutique.

Publications (1)

Publication Number Publication Date
ATE183742T1 true ATE183742T1 (de) 1999-09-15

Family

ID=9447217

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94401032T ATE183742T1 (de) 1993-05-17 1994-05-10 2-aminopyrazin-5-carbonsäureamid derivate, deren herstellung und deren verwendung als heilmittel

Country Status (19)

Country Link
US (1) US5420130A (de)
EP (1) EP0625514B1 (de)
JP (1) JPH06329645A (de)
CN (1) CN1104637A (de)
AT (1) ATE183742T1 (de)
AU (1) AU671361B2 (de)
CA (1) CA2123668A1 (de)
CZ (1) CZ283499B6 (de)
DE (1) DE69420179D1 (de)
FI (1) FI942265L (de)
FR (1) FR2705344B1 (de)
HU (1) HUT69711A (de)
IL (1) IL109655A (de)
NO (1) NO941830L (de)
NZ (1) NZ260531A (de)
PL (1) PL173309B1 (de)
RU (1) RU2128176C1 (de)
SK (1) SK57494A3 (de)
ZA (1) ZA943353B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA00010805A (es) * 1998-05-06 2002-05-08 Univ Duke Metodo para el tratamiento de sindromes de la vejiga y del tracto urinario inferior.
PL200955B1 (pl) 1998-08-20 2009-02-27 Toyama Chemical Co Ltd Przeciwwirusowa kompozycja farmaceutyczna i jej zastosowanie oraz zawierająca azot heterocykliczna pochodna karboksamidu

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4041032A (en) * 1974-01-16 1977-08-09 Yamanouchi Pharmaceutical Co., Ltd. Pyrazine derivatives
GB8712365D0 (en) * 1987-05-26 1987-07-01 Ici America Inc Aminomethylphenolic pyrazines
FR2656609B1 (fr) * 1989-12-28 1992-03-27 Synthelabo Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.

Also Published As

Publication number Publication date
DE69420179D1 (de) 1999-09-30
RU2128176C1 (ru) 1999-03-27
NO941830D0 (no) 1994-05-16
FI942265A7 (fi) 1994-11-18
FR2705344A1 (fr) 1994-11-25
IL109655A0 (en) 1994-08-26
FI942265L (fi) 1994-11-18
CZ283499B6 (cs) 1998-04-15
CN1104637A (zh) 1995-07-05
CA2123668A1 (en) 1994-11-18
IL109655A (en) 1999-03-12
CZ119594A3 (en) 1994-12-15
EP0625514B1 (de) 1999-08-25
HUT69711A (en) 1995-09-28
JPH06329645A (ja) 1994-11-29
US5420130A (en) 1995-05-30
AU671361B2 (en) 1996-08-22
ZA943353B (en) 1995-03-28
NZ260531A (en) 1995-10-26
RU94016363A (ru) 1996-04-10
HU9401512D0 (en) 1994-08-29
AU6312694A (en) 1994-11-24
PL173309B1 (pl) 1998-02-27
EP0625514A1 (de) 1994-11-23
FI942265A0 (fi) 1994-05-16
NO941830L (no) 1994-11-18
SK57494A3 (en) 1995-07-11
FR2705344B1 (fr) 1995-06-30

Similar Documents

Publication Publication Date Title
TW330202B (en) Substituted heterocyclic carboxamide esters, their preparation and their use as pharmaceuticals
ATE542805T1 (de) Ppar-delta aktivatoren
IL147651A0 (en) Isoxazoline derivative and herbicide containing the same as the active ingredient
NO924783L (no) Terapeutiske midler
TR200000736T2 (tr) İkame edilmiş kroman türevleri.
DE68903680D1 (de) 6-phenyl-3-piperazinylalkyl-1h,3h-pyrimidindion-2,4-derivate, deren herstellung und verwendung als heilmittel.
ATE166648T1 (de) Benzoxazinderivate, deren herstellung und deren verwendung in therapie
DE68908643D1 (de) Mercapto-phenylalkanoylaminosäure-Amide, deren Herstellung und deren Verwendung als Collagenase-Inhibitoren.
ATE111460T1 (de) 2-(aminoalkyl)-5-(arylalkyl)1,3-dioxanderivate, ihre herstellung und ihre anwendung in der therapeutik.
DE69324212D1 (de) Indol-7-carboxamide Derivate als Analgetika
ATE83234T1 (de) Oxadiazol-pyrimidinone, ihre herstellung und ihre kosmetische und dermopharmazeutische verwendung.
ATE80384T1 (de) Sulfurierte eicosanoide und deren verwendung in arzneimitteln und kosmetika.
ATE183742T1 (de) 2-aminopyrazin-5-carbonsäureamid derivate, deren herstellung und deren verwendung als heilmittel
ATE204880T1 (de) N-acyldipeptide, und pharmazeutische präparate davon
ATE209197T1 (de) Imidazolidinon-derivate, deren säure- additionssalze und mittel gegen senile demenz
ATE123025T1 (de) 2-amino-n-(((4-(aminocarbonyl)pyrimidin-2- yl>amino>alkyl>-pyrimidin-4- carbonsäureamidderivate, ihre herstellung und ihre anwendung in der therapeutica.
ATE28639T1 (de) Derivate von 4-(3-alkynyloxy-2-hydroxy-propyl)piperazin-1-yl-n-phenylacetamid, ihre herstellung und ihre therapeutische verwendung.
ATE71370T1 (de) 2-amino-5-hydroxy-4-pyrimidone.
ATE58536T1 (de) 5-aminoalkyl-beta-carbolinderivate, ihre herstellung und verwendung als arzneimittel.
ATE2786T1 (de) 1-(2-propynyloxy)-2-amino-3-propanol-aether, ihre herstellung und sie enthaltende pharmazeutische zusammensetzung.
ATE213415T1 (de) Substituierte 6-h-1,3,4,-thiadiazin-2-amine, deren verwendung als anaesthetisierende, cardiovaskulare und hypometabolische mittel, und eine sie enthaltende pharmazeutische zubereitung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties